Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Reports 9-Percent Increase in Q4 Sales; Consumables Segment Jumps 11 Percent

NEW YORK, Feb. 14 (GenomeWeb News) - Qiagen yesterday reported a 9-percent increase in sales and a 6-percent rise in net profit for the fourth quarter.

 

Revenues for the three months ended Dec. 31, 2005, increased to $104.3 million from $95.5 million in the year-ago period.

 

Qiagen's net income for the fourth quarter rose to $16.9 million from $15.8 million in Q4 2004.

 

The company's consumables business, which contributed about 88 percent to net sales, grew approximately 11 percent in the fourth quarter compared with the same period one year ago.

 

R&D expenses for the fourth quarter rose to $10.7 million from $9.5 million in Q4 2004, Qiagen said.

 

As of Dec. 31, Qiagen had approximately $191.7 million in cash and cash equivalents on hand.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.